When Do Late Effects in Childhood Cancer Survivors Cease Emerging? The Endocrine Answer [EDITORIALS]
(Source: Journal of Clinical Oncology)
Source: Journal of Clinical Oncology - September 12, 2016 Category: Cancer & Oncology Authors: Greenberg Tags: Long Term Survival & Late Effects EDITORIALS Source Type: research

Advertising [ONCOLOGY CAREER CENTER]
(Source: Journal of Clinical Oncology)
Source: Journal of Clinical Oncology - September 12, 2016 Category: Cancer & Oncology Tags: ONCOLOGY CAREER CENTER Source Type: research

Erratum [erratum]
(Source: Journal of Clinical Oncology)
Source: Journal of Clinical Oncology - August 30, 2016 Category: Cancer & Oncology Tags: ERRATUM Source Type: research

Reply to L.J. Eapen et al [CORRESPONDENCE]
(Source: Journal of Clinical Oncology)
Source: Journal of Clinical Oncology - August 30, 2016 Category: Cancer & Oncology Authors: Sonpavde Tags: CORRESPONDENCE Source Type: research

Management Considerations After Cystectomy for Bladder Cancer [CORRESPONDENCE]
(Source: Journal of Clinical Oncology)
Source: Journal of Clinical Oncology - August 30, 2016 Category: Cancer & Oncology Authors: Eapen, MacRae Tags: CORRESPONDENCE Source Type: research

Reply to R. Colomer et al [CORRESPONDENCE]
(Source: Journal of Clinical Oncology)
Source: Journal of Clinical Oncology - August 30, 2016 Category: Cancer & Oncology Authors: Durkee, Qian, Goldhaber-Fiebert, Horst Tags: CORRESPONDENCE Source Type: research

Is Metastatic Disease the Best Setting for Cost-Effectiveness Studies? [CORRESPONDENCE]
(Source: Journal of Clinical Oncology)
Source: Journal of Clinical Oncology - August 30, 2016 Category: Cancer & Oncology Authors: Colomer, Pascual, Albanell Tags: CORRESPONDENCE Source Type: research

Reply to E.M. Ruggeri et al and Y.-W. Hu [CORRESPONDENCE]
(Source: Journal of Clinical Oncology)
Source: Journal of Clinical Oncology - August 30, 2016 Category: Cancer & Oncology Authors: Galsky, Moshier, Wisnivesky, Mazumdar Tags: CORRESPONDENCE Source Type: research

Real-World Role of Adjuvant Chemotherapy in Bladder Cancer [CORRESPONDENCE]
(Source: Journal of Clinical Oncology)
Source: Journal of Clinical Oncology - August 30, 2016 Category: Cancer & Oncology Authors: Hu Tags: CORRESPONDENCE Source Type: research

Should We Use Adjuvant Chemotherapy for Muscle-Invasive Bladder Cancer After Radical Cystectomy? [CORRESPONDENCE]
(Source: Journal of Clinical Oncology)
Source: Journal of Clinical Oncology - August 30, 2016 Category: Cancer & Oncology Authors: Ruggeri, Fabbri, Nelli Tags: CORRESPONDENCE Source Type: research

Oncologists Guilt [ART OF ONCOLOGY]
(Source: Journal of Clinical Oncology)
Source: Journal of Clinical Oncology - August 30, 2016 Category: Cancer & Oncology Authors: Caram Tags: Emotions of the oncologist, All Art of Oncology Articles Source Type: research

Innovations in American Society of Clinical Oncology Practice Guideline Development [ASCO SPECIAL ARTICLE]
Since the beginning of its guidelines program in 1993, ASCO has continually sought ways to produce a greater number of guidelines while maintaining its commitment to using the rigorous development methods that minimize the biases that threaten the validity of practice recommendations. ASCO is implementing a range of guideline development and implementation innovations. In this article, we describe innovations that are designed to (1) integrate consideration of multiple chronic conditions into practice guidelines; (2) keep more of its guidelines current by applying evolving signals or (more) rapid, for-cause updating approa...
Source: Journal of Clinical Oncology - August 30, 2016 Category: Cancer & Oncology Authors: Somerfield, Bohlke, Browman, Denduluri, Einhaus, Hayes, Khorana, Miller, Mohile, Oliver, Ortiz, Lyman Tags: ASCO Guidelines ASCO SPECIAL ARTICLE Source Type: research

Efficacy of Tumor Vaccines and Cellular Immunotherapies in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis [REVIEW ARTICLE]
Conclusion Tumor vaccines and cellular immunotherapies enhanced OS and PFS in NSCLC. Cellular immunotherapy was found to be more effective than tumor vaccination. These findings have implications for future studies investigating combination immunotherapy in NSCLC. (Source: Journal of Clinical Oncology)
Source: Journal of Clinical Oncology - August 30, 2016 Category: Cancer & Oncology Authors: Dammeijer, Lievense, Veerman, Hoogsteden, Hegmans, Arends, Aerts Tags: Chemotherapy, Combined Modality REVIEW ARTICLE Source Type: research

Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study [Pediatric Oncology]
Conclusion Gain of 1q is a potentially valuable prognostic biomarker in WT, in addition to histologic response to preoperative chemotherapy and tumor stage. (Source: Journal of Clinical Oncology)
Source: Journal of Clinical Oncology - August 30, 2016 Category: Cancer & Oncology Authors: Chagtai, Zill, Dainese, Wegert, Savola, Popov, Mifsud, Vujanić, Sebire, Le Bouc, Ambros, Kager, O'Sullivan, Blaise, Bergeron, Mengelbier, Gisselsson, Kool, Tytgat, van den Heuvel-Eibrink, Graf, van Tinteren, Coulomb, Gessler, Williams, Pritchard-Jo Tags: Translational Oncology, Renal Tumors, Wilms' Tumor: Therapy, Genitourinary, Cancer Biomarkers, Pediatric, Chromosomal Abnormalities Pediatric Oncology Source Type: research

Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Childrens Oncology Group [Pediatric Oncology]
Conclusion Gain of 1q is associated with inferior survival in unilateral FHWTs and may be used to guide risk stratification in future studies. (Source: Journal of Clinical Oncology)
Source: Journal of Clinical Oncology - August 30, 2016 Category: Cancer & Oncology Authors: Gratias, Dome, Jennings, Chi, Tian, Anderson, Grundy, Mullen, Geller, Fernandez, Perlman Tags: Renal Tumors, Wilms' Tumor: Therapy Pediatric Oncology Source Type: research